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Abstract 
The European Academy of Allergy and Clinical Immunology (EAACI) owns three journals: Allergy, Pediatric Allergy and 
Immunology and Clinical and Translational Allergy. One of the major goals of EAACI is to support health promotion in 
which prevention of allergy and asthma plays a critical role and to disseminate the knowledge of allergy to all stake-
holders including the EAACI junior members.
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The European Academy of Allergy and Clinical Immu-
nology (EAACI) has three official journals: Allergy, Pedi-
atric Allergy and Immunology and Clinical and Trans-
lational Allergy. One of the major goals of EAACI is to 
support health promotion in which prevention of allergy 
plays a critical role and to disseminate the knowledge of 
allergy to all stakeholders including the EAACI junior 
members [1].
The EAACI journals have reported on the prediction 
and primary and secondary prevention of allergic dis-
eases and asthma in 2016. This paper summarises these 
achievements.
Risk and protective factors
IgE-mediated allergy is much more common in Finnish 
compared with Russian Karelia, although these areas are 
geographically and genetically close. Many studies are 
trying to find the reasons explaining these differences. 
Higher concentrations of common environmental chemi-
cals were measured in Russian compared with Finnish 
Karelian children and their mothers [2]. The chemicals 
did not explain the higher prevalence of atopy on the 
Finnish side.
Atopic dermatitis (AD) is a chronic inflammatory skin 
condition with a multifactorial pathogenesis. Several 
perinatal factors may influence the risk of AD. In a Dan-
ish nationwide register-based study [3], the risk of devel-
oping AD in the first 5 years of life was examined. Low 
birth  weight and preterm birth were inversely associ-
ated with a lower risk of AD, while neonatal jaundice and 
birth during autumn or winter were associated with an 
increased risk of AD.
The prevalence of childhood AD varies considerably 
between ethnic groups. The Generation R Study assessed 
the role of environmental exposures and filaggrin (FLG) 
mutations on associations between ethnic origin and risk of 
childhood AD in 5082 children [4]. Compared with Dutch 
children, Cape Verdean, Dutch Antillean, Surinamese-
Creole and Surinamese-Hindustani children had increased 
risks of AD in the first 4 years of life. Environmental and 
genetic risk factors partly weakened these associations.
Early gut colonization by Bifidobacterium breve and B. 
catenulatum differentially modulates AD risk in children 
at high risk of developing allergic disease [5]. Faecal sam-
ples were collected at age 1 week, 1 month and 3 months 
from 117 infants at high risk of allergic disease. Temporal 
variations in Bifidobacterium colonization patterns early 
in life are associated with later development of eczema 
and/or atopic sensitization in infants at high risk of aller-
gic disease.
Evidence linking maternal psychosocial stress during 
pregnancy to subsequent child AD is growing, but the 
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definition of AD is diverse and results are inconsistent. 
The first systematic review to date addressed prenatal 
maternal stress and the subsequent risk of atopy-related 
outcomes in the child [6]. Results suggest a relationship 
between maternal stress during pregnancy and atopic 
disorders in the child. However, the existing studies are 
of diverse quality and the wide definitions of often self-
reported stress exposures imply a substantial risk for 
information bias and false-positive results.
Routine vaccinations can have non-targeted effects 
on susceptibility to infections and allergic disease. Such 
effects may depend on age at vaccination, and a delay in 
pertussis vaccination has been linked to reduced risk of 
allergic disease. In a population-based cohort of Mel-
bourne, HealthNuts, 4433 12-month-old infants had 
skin tests and oral challenges to determine food allergy 
[7]. There was no overall association between delayed 
Diphtheria, Tetanus, Pertusis (DTaP) vaccination and 
food allergy; however, children with delayed DTaP had 
less AD and less use of AD medication. Timing of routine 
infant immunizations may affect susceptibility to allergic 
disease.
Body mass index (BMI) and physical activity in early 
childhood are inconsistently associated with atopic sen-
sitization, AD and asthma in later childhood. Higher BMI 
and over or under physical activities in early childhood 
were associated with atopic sensitization, AD and asthma 
in later childhood [8]. Larger cohorts with repeated 
measurements of both predictors and outcomes are 
required to confirm the data.
Greater infant weight gain is associated with lower lung 
function and increased risk of childhood asthma. The 
role of early childhood peak growth patterns is unclear. 
A population-based prospective cohort study among 
5364 children assessed repeated growth measurements 
between 0 and 3 years of age as well as BMI and age at 
adiposity peak [9]. Respiratory resistance and fractional 
exhaled nitric oxide were measured at 6  years of age. 
Greater peak height and weight velocities (PHV) were 
associated with lower respiratory resistance. Greater 
peak weight velocity (PWV) and BMI at adiposity peak 
were associated with increased risks of early and persis-
tent wheezing. Childhood weight status partly explained 
these associations. No other associations were observed. 
Follow-up studies at older ages are needed to elucidate 
whether these effects persist at later ages.
The increased prevalence of atopic diseases has been 
largely studied in children and adolescents, but fewer 
data exist in adults. Results from the cross-sectional 
West Sweden Asthma Study in 30,000 randomly-selected 
individuals showed that there are different risk factor 
patterns for asthma, rhinitis and eczema in adults with 
some risk factors overlapping between these conditions. 
Allergic sensitization was a strong risk factor for current 
asthma and current rhinitis but not for current eczema. 
Obesity was a risk factor for current asthma and cur-
rent rhinitis, while farm childhood decreased the risk for 
current asthma and rhinitis. Occupational exposure to 
gas dust or fumes and female sex was associated with an 
increased risk of current asthma and eczema [10].
Allergen exposure is associated with the develop-
ment of allergic sensitization in childhood as reflected 
by global variations in sensitization patterns. However, 
there is little evidence to support a direct association. The 
Copenhagen Prospective Study on Asthma in Childhood 
2000 birth cohort showed in children of 7 and 13  years 
that perinatal indoor aeroallergen exposure does not 
seem to affect development of allergic sensitization or 
rhinitis during childhood [11].
Finally, a hypothesis was proposed: may e-cigarette 
vaping boost the allergic epidemic by affecting human 
host defences, Staphylococcus aureus virulence and IgE 
sensitization? [12].
Allergic March
Infants hospitalized for severe bronchiolitis are at 
increased risk of childhood asthma. A nested cohort 
study within the Massachusetts General Hospital Obstet-
ric Maternal Study (MOMS) carried out a prospective 
cohort of pregnant women enrolled during 1998–2006 
(n  =  5407) [13]. AD was significantly associated with 
severe bronchiolitis in infancy. The mechanism of the 
AD-bronchiolitis association is unclear.
Mechanisms
Finnish and Russian Karelian children have a highly con-
trasting occurrence of asthma and allergy: The methyla-
tion levels in the promoter region of the CD14 gene were 
higher in the Finnish compared to Russian Karelian chil-
dren. However, the methylation variation of this candi-
date gene did not explain the asthma and allergy contrast 
between these two areas and the answer is not simple 
[14].
The role of FLG mutations during pregnancy and post-
partum is unknown. FLG-genotyping was performed in 
a population-based sample of 1837 women interviewed 
in the 12th and 30th weeks of pregnancy and 6 months 
postpartum as part of the Danish National Birth Cohort 
study 1996–2002. Women with FLG mutations had 
an increased risk of AD flares during pregnancy and of 
enduring postpartum physical problems linked to per-
ineal trauma during delivery [15].
First-born children are at higher risk of develop-
ing a range of immune-mediated diseases and may 
have a  divergent activated T-cells  profile suggesting in 
utero programming of the child’s immune system. In a 
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subgroup of 28 children enrolled in the COPSAC2010 
birth cohort, it was found that first-born infants display 
a reduced anti-inflammatory profile in  Tv-cells  at birth. 
This possible in utero ‘birth-order’ T-cells programming 
may contribute to a later development of immune-medi-
ated diseases by increasing overall immune reactivity in 
first-born children as compared to younger siblings [16].
Although total IgE levels have been proposed as a bio-
marker for disease severity in AD and are increased in 
the majority of AD patients, they do not correlate with 
disease severity. During the synthesis of immunoglobu-
lins, free light chains (Ig-FLCs) are produced in excess 
over heavy chains. In comparison with IgE molecules, 
Ig-FLCs have a very short serum half-life. Therefore, Ig-
FLCs might be more suitable as a biomarker for disease 
severity during follow-up. However, immunoglobulin 
free light chains in adult AD patients do not correlate 
with disease severity [17].
Epigenetics
DNA methylation in adulthood is associated with season 
of birth, supporting the hypothesis that DNA methyla-
tion could mechanistically underlie the effect of season 
of birth on allergy, although other mechanisms are also 
likely to be involved [18]. There may be  an association 
between season of birth and blood DNA methylation in 
adulthood but a recent study was unable to replicate pre-
vious findings and the question is still open [19].
Early environmental factors are likely to contribute 
to CMA. In a small sample size from the Dutch Euro-
Prevall birth cohort study (N =  20 CMA, N =  23 con-
trols, N  =  10 tolerant boys), general hypermethylation 
was found in the CMA group compared to control chil-
dren, while this effect was absent in the tolerant group 
[20]. Methylation differences were, among others, found 
in regions of DHX58, ZNF281, EIF42A and HTRA2 
genes. Several of these genes are associated with allergic 
diseases.
Consumption of unboiled farm milk in early life pre-
vents the development of atopic diseases. Milk is a com-
plex signalling and epigenetic imprinting network that 
promotes stable FoxP3 expression and long-lasting Treg 
differentiation, crucial postnatal events preventing atopic 
and autoimmune diseases [21].
Prediction
Profiles of allergic sensitization are poorly documented 
in infancy. Early polysensitization is associated with aller-
gic multimorbidity in the Pollution and Asthma Risk: an 
Infant Study (PARIS) birth cohort of infants [22] as early 
as 18 months of age. Three profiles were found, differing 
in terms of allergic morbidity at 6 years. Early sensitiza-
tion can predict allergic multimorbidity in childhood, 
and in the case of early polysensitization, multimorbidity 
is more frequent as early as infancy [23].
The longitudinal pattern of allergen-specific IgE levels 
from the prenatal stage to early life has remained largely 
unexplored. 103 mother-infant pairs, part of an ongoing 
population-based prospective birth cohort study in Tai-
wan, found that an influence of maternal allergen-specific 
IgE levels on infant immune response might occur at 
birth and then wane in infants at 12 months of age [24].
A  longitudinal study of maternal body mass index, 
gestational weight gain, and offspring asthma was car-
ried out in the Growing Up Today Study [25]. Physician-
diagnosed asthma during childhood or adolescence was 
reported by 2694 children (21%). Maternal prepregnancy 
overweightness and obesity were associated with off-
spring asthma. The relation of several prenatal factors 
to risk of childhood asthma supports the early origins 
hypothesis for asthma.
Prevention
Breastfeeding is associated with a lower risk of asthma 
symptoms in early childhood, but its effect at older 
ages remains unclear. The Food Allergy and Intolerance 
Research (FAIR) cohort (n  =  988) [26] showed incon-
sistent protective effects of nonexclusive and exclusive 
breastfeeding against long-term allergic outcomes. The 
Generation R Study [27] examined the associations of 
duration and exclusiveness of breastfeeding with asthma 
outcomes in children aged 6  years, and whether these 
associations were explained by atopic or infectious mech-
anisms. Breastfeeding patterns may influence wheez-
ing and asthma in childhood, which seem to be partly 
explained by infectious mechanisms.
Prevention guidelines for infants at high risk of aller-
gic disease recommend hydrolysed formula if formula is 
introduced before 6 months, but evidence is mixed. Add-
ing specific oligosaccharides may improve outcomes. A 
partially hydrolysed whey formula containing oligosac-
charides does not prevent AD in the first year in high-
risk infants [28]. The immunological changes (increased 
regulatory T-cell and plasmacytoid dendritic cell per-
centages) that were found require confirmation in a sepa-
rate cohort.
Data on the long-term impact of hydrolyzed formulas 
on allergies are scarce. The GINI (German Infant Study 
on the influence of Nutrition Intervention) trial partici-
pants (n  =  2252) received one of four formulas in the 
first four months of life as breast milk substitute if nec-
essary: partial or extensive whey hydrolyzate (pHF-W, 
eHF-W), extensive casein hydrolyzate (eHF-C) or stand-
ard cow’s milk formula (CMF) as Ref. [29]. Between 11 
and 15  years, the prevalence of asthma and the cumu-
lative incidence of AR were reduced in the eHF-C. The 
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cumulative incidence of AD was reduced in pHF-W and 
eHF-C, AD prevalence was reduced in eHF-C. No sig-
nificant effects were found in the eHF-W group on any 
manifestation, nor was there an effect on sensitization 
with any formula. In high-risk children, early interven-
tion using different hydrolyzed formulas has variable pre-
ventative effects on asthma, allergic rhinitis and AD up to 
adolescence.
Nutritional adequacy of a cow′s milk exclusion diet 
in infancy is essential since infants with suspected 
cow’s milk allergy are required to follow a strict milk 
exclusion diet [30]. In a group of UK infants (subgroup 
of the Prevalence of Infant Food Allergy study), the 
diets of 39 infants (13 milk-free and 26 controls) were 
assessed. Although infants consuming a milk-free diet 
have a nutritional intake that is significantly different to 
matched controls who are eating an unrestricted diet, 
this difference is not constant and it is not seen for all 
nutrients.
The impact of the elimination diet on growth and nutri-
ent intake in children with food protein induced gastro-
intestinal allergies was examined in children with delayed 
type allergies [31]. A prospective, observational study was 
performed at a tertiary gastroenterology department in 
children ranging in age from 4  weeks to 16  years. With 
appropriate dietary advice, including optimal energy and 
protein intake, hypoallergenic formulas and vitamins and 
mineral supplementation, growth parameters increased 
from before to after dietary elimination. These factors 
were positively associated with growth, irrespective of 
the type of elimination diet and the numbers of foods 
eliminated.
The prevalence of food hypersensitivity in the UK is 
still largely open to debate [32]. In a population based 
birth cohort study conducted in Hampshire, UK as part 
of the European Initiative on Food Allergy, EuroPrevall, 
birth cohort study, 1140 infants were recruited with 823 
being followed up until 2  years of age. The diagnosis of 
food allergy was ascertained by positive double-blind, 
placebo-controlled food challenge (DBPCFC). Cumula-
tive incidence of food hypersensitivity by 2 years of age 
was 5.0%. The cumulative incidence for individual food 
allergens were hens’ egg 2.7% (1.6–3.8); cows’ milk 2.4% 
(1.4–3.5); peanut 0.7% (0.1–1.3); soy 0.4% (0.0–0.8); 
wheat 0.2% (0.0–0.5) and 0.1% (0.0–0.32) for fish. Just 
under half the infants with confirmed food hypersensitiv-
ity had no demonstrable IgE.
In the Probiotics in Prevention of Allergy among 
Children in Trondheim (ProPACT, n  =  259) study, AD 
prevention in children following maternal probiotic sup-
plementation does not appear to be mediated by breast 
milk TSLP or TGF-beta [33].
The political agenda
Preventive strategies for allergic diseases need to be 
anchored on a strong political agenda to implement the 
results of the research into practice. The European Sym-
posium on Precision Medicine in Allergy and Airways 
Diseases at the European Union Parliament (October 14, 
2015) stressed that the socioeconomic impact of allergies 
and chronic airways diseases cannot be underestimated 
[34]. Participants underscored the need for optimal 
patient care in Europe, supporting joint action plans for 
disease prevention, patient empowerment, and cost-
effective treatment strategies. AIRWAYS-ICPs (Inte-
grated care pathways for airway diseases, Action Plan B3 
of the European Innovation Partnership on Active and 
Healthy Ageing, DG Santé and DG Connect) focuses on 
the prevention and integrated care of chronic diseases. It 
has proposed a scale-up strategy for the management and 
prevention of allergic diseases using the recommenda-
tions of the European Innovation Partnership on Active 
and Healthy Ageing [35]. ARIA, the Allergic Rhinitis 
and its Impact on Asthma (ARIA) initiative commenced 
during a World Health Organization workshop in 1999, 
is also targeting preventive strategies to prevent asthma 
and rhinitis by implementing emerging technologies 
using the ARIA Allergy Diary app and the ARIA allergy 
companion  app [36]. In close collaboration with the 
European Forum for Research and Education in Allergy 
and Airways diseases (EUFOREA) [37], an action plan for 
increasing awareness on prevention, patient empower-
ment and cost-effective treatments is being elaborated.
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